Liu; Chuanju

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liu; Chuanju.The latest application filed is for "compositions and methods for treatment of inflammatory autoimmune diseases".

Company Profile

4.9.9

Liu; Chuanju - Orange CT
LIU; Chuanju - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Progranulin (PGRN) fragments and derivatives for treatment or alleviation of lysosomal storage diseases Grant 11,390,656 - Liu , et al. July 19, 2	2022-07-19
Compositions And Methods For Treatment Of Inflammatory Autoimmune Diseases App 20200022964 - Liu; Chuanju	2020-01-23
Progranulin And Progranulin Derivatives In Treating Impaired Fracture Healing App 20190388508 - LIU; Chuanju ; et al.	2019-12-26
Progranulin (PGRN) and its derivatives for diagnosis and treatment of lysosomal storage diseases Grant 10,357,542 - Liu , et al. July 23, 2	2019-07-23
Progranulin (pgrn) Fragments And Derivatives For Treatment Or Alleviation Of Lysosomal Storage Diseases App 20180222952 - LIU; Chuanju ; et al.	2018-08-09
Progranulin (pgrn) And Its Derivatives For Diagnosis And Treatment Of Lysosomal Storage Diseases App 20170049855 - Liu; Chuanju ; et al.	2017-02-23
Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof Grant 8,871,915 - Liu October 28, 2	2014-10-28
Granulin/epithelin precursor (GEP), a chondrogenic growth factor and target in cartilage disorders Grant 8,536,128 - Liu , et al. September 17, 2	2013-09-17
Peptides Targeting Tnf Family Receptors And Antagonizing Tnf Action, Compositions, Methods And Uses Thereof App 20130157945 - LIU; Chuanju	2013-06-20
Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof Grant 8,362,218 - Liu January 29, 2	2013-01-29
GEP, a novel chondrogenic growth factor and target in cartilage disorders App 20120230942 - Liu; Chuanju ; et al.	2012-09-13
Methods for using GEP, a chondrogenic growth factor and target in cartilage disorders Grant 7,928,068 - Liu , et al. April 19, 2	2011-04-19
Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof App 20100298232 - Liu; Chuanju	2010-11-25
GEP, a novel chondrogenic growth factor and target in cartilage disorders App 20090226370 - Liu; Chuanju ; et al.	2009-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.